glp 1 for liver GLP-1 Receptor Agonists in Non-Alcoholic Fatty Disease: Current Evidence and Future Perspectives A Comprehensive Review of the
Description
But now that youre coming off the medication, youll need to continue to choose smaller portions, even if your appetite tells you otherwise

They also enhance mitochondrial function by upregulating PGC-1, restoring energy production and reducing cell death [24]

The problem is that these Glucagon-like peptide-1 (GLP-1) drugs were initially approved to treat type 2 diabetes, and later received approval as weight-loss medications, researchers said

[1] These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)

In contrast, Wegovy may cause inflammation of the pancreas (pancreatitis), gallbladder problems, and thyroid tumors
